NCT02835651 is a NA clinical trial of Palmitic acid in Dyslipidemia, sponsored by Maastricht University Medical Center.

Who is sponsoring NCT02835651?

NCT02835651 is sponsored by Maastricht University Medical Center.

What drugs are being tested in NCT02835651?

Interventions in NCT02835651: Palmitic acid, Stearic acid.

What condition does NCT02835651 study?

NCT02835651 studies Dyslipidemia.

Is NCT02835651 still recruiting?

NCT02835651 is currently completed. Last updated 22 August 2017.

Last reviewed 2017-08-22 · How we verify

NCT02835651

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Saturated Fatty Acids and HDL Metabolism

Completed NA Last updated 22 August 2017

What this trial tests

NA trial testing Palmitic acid in Dyslipidemia in 41 participants. Completed in 1 July 2017.

Timeline

14 April 2016

Primary endpoint
1 July 2017

1 July 2017

Quick facts

Lead sponsor	Maastricht University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	prevention
Enrollment	41
Start date	14 April 2016
Primary completion	1 July 2017
Estimated completion	1 July 2017
Sites	1 location across Netherlands

Drugs / interventions tested

Palmitic acid
Stearic acid (stearic acid) — full drug profile →

Conditions studied

Dyslipidemia — all drugs for Dyslipidemia →

Sponsor

Maastricht University Medical Center

Who can join

Adults 45 to 70, any sex, with Dyslipidemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether palmitic acid (C16:0) and stearic acid (C18:0) have different effects on HDL metabolism during the fasted state.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Dietary stearic acid and palmitic acid do not differently affect ABCA1-mediated cholesterol efflux capacity in healthy men and postmenopausal women: A randomized controlled trial.
van Rooijen MA, Plat J, Blom WAM, Zock PL, et al · · 2021 · cited 15× · PMID 32900520 · DOI 10.1016/j.clnu.2020.08.016
Effects of two consecutive mixed meals high in palmitic acid or stearic acid on 8-h postprandial lipemia and glycemia in healthy-weight and overweight men and postmenopausal women: a randomized controlled trial.
van Rooijen MA, Plat J, Zock PL, Blom WAM, et al · · 2021 · cited 7× · PMID 33733339 · DOI 10.1007/s00394-021-02530-2

Verify or expand the search:

Other recruiting trials for Dyslipidemia

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
NCT06919302 — The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care. · NA · recruiting
NCT07162441 — A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and · Phase 1 · recruiting
NCT07043166 — Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens · recruiting

Other Maastricht University Medical Center trials

Trials by the same sponsor.

NCT04603261 — Time to Excretion of Contrast, a Maastricht Prospective Observational Study · withdrawn
NCT04598516 — Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30 · withdrawn
NCT04597892 — Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast · withdrawn
NCT07287358 — Optimal Cerebral Perfusion Pressure Guided Therapy: Assessment of Target Effectiveness - II · NA · not yet recruiting
NCT07501780 — Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02835651 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maastricht University Medical Center
Last refreshed: 22 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02835651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing